Skip to content

MDMA research published in 2005

37 studies whose primary subject is MDMA were published in 2005, down from 55 in 2004. Newest first. Back to the MDMA overview

Studies

Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.

Journal of Emergency Medicine November 2005 Manish M Patel, Martin G Belson, Adam B Longwater et al.

MDMA (or 3, 4 methylenedioxymethamphetamine) was first manufactured in the 1920s and found to have structural similarities to both mescaline and amphetamines. Used briefly by some therapists in the 1970s and early 1980s as an adjunct to psychotherapy, it is now primarily abused by teenagers and young adults as an illicit recreational drug known as "ecstasy." As its popularity has increased, so...

Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine

Journal of Psychopharmacology November 1, 2005 Kim P. C. Kuypers, Jan Ramaekers 88 citations

A range of studies has indicated that users of 3.4-Methylene-dioxymethamphetamine (MDMA, 'Ecstasy') display cognitive deficits, particularly memory impairment, as compared to non-drug using controls. Yet it is difficult to determine whether these deficits are caused by MDMA or some other confounding factor, such as polydrug use. The present study was designed to establish the direct relation...

Acute medical problems due to Ecstasy use. Case-series of emergency department visits.

October 29, 2005 Matthias E. Liechti, Isabelle Kunz, Hugo Kupferschmidt 58 citations

STUDY AIM: To describe the clinical characteristics of Ecstasy (3,4-Methylenedioxymethamphetamine, MDMA) toxicity. METHODS: Retrospective case-study of 52 self-reported Ecstasy intoxications presenting to our Emergency Department (ED) between January 2001 and December 2003. RESULTS: Most patients ingested Ecstasy together with other substances, including alcohol (51.9%) or other illicit drugs...

DOI: 10.4414/smw.2005.11231 (opens in new tab) Ecstasy Emergency department Rhabdomyolysis Coma optics +2

Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits.

Pharmacology, Biochemistry, and Behavior September 9, 2005 S. Moyano, J. Del Río, D. Frechilla 29 citations

Acute 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") treatment induces learning deficits in different animal models. In a passive avoidance learning task in rats, previous studies suggested a role for Ca2+/calmodulin-dependent protein kinase II (CaMKII) and N-methyl-D-aspartate (NMDA) receptors in the acute learning impairment. As cognitive deficits by "ecstasy" in humans have been only...

DOI: 10.1016/j.pbb.2005.07.020 (opens in new tab) Hippocampus Animals Rats, wistar N-methyl-3,4-methylenedioxyamphetamine +6

The P3 in ‘ecstasy’ polydrug users during response inhibition and execution

Journal of Psychopharmacology September 1, 2005 Alex Gamma, Daniel Brandeis, Ruven Brandeis et al. 36 citations

Substance abuse and associated externalizing disorders are characterized by behavioural disinhibition and low impulse control, with reduced neural inhibition postulated to be the common underlying brain mechanism. The P3 component of event-related potentials (ERPs) is a widely used neurophysiological measure thought to reflect inhibitory brain processes, but as yet has not been assessed in...

Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats.

Neuropsychopharmacology August 2005 June M Young, Iain S. Mcgregor, Paul E Mallet

3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') and cannabis are two of the most commonly used illicit drugs in the western world, and are often used in combination. Very little research has examined their effect on cognitive function or behavior when combined, The present study used a double Y-maze task to examine the acute effect of MDMA and delta9-tetrahydrocannabinol (THC, the principal...

Neuropsychiatric Alterations in MDMA Users: Preliminary Findings

Annals of the New York Academy of Sciences August 1, 2005 Ronald I. Herning 17 citations

The use of marijuana is rampant among 3,4-methylenedioxymethamphetamine (MDMA) users. The co-occurrence of abuse of these two drugs has made it difficult to assess the specific residual effects of MDMA alone. As a first step toward identifying the effects of long-term MDMA use, we studied 8 MDMA abusers, 8 marijuana/MDMA abusers, 15 marijuana abusers (matched in marijuana use without MDMA use),...

DOI: 10.1196/annals.1344.003 (opens in new tab) MDMA Ecstasy Electroencephalography Hallucinogen +3

Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats

The International Journal of Neuropsychopharmacology August 1, 2005 Eszter Kirilly, Anita Benkő, Linda Ferrington et al. 26 citations

MDMA causes selective depletion of serotonergic terminals in experimental animals and the consequent decrease in synaptic 5-HT may, inter alia, increase impulsivity. To study the effects of MDMA upon brain function, the behaviour of male Dark Agouti rats exposed to MDMA (15 mg/kg i.p.), two 5-HT1B agonists (CGS-12066A and CP-94,253, both 5 mg/kg i.p.) or saline were investigated in the...

3,4-Methylenedioxymethamphetamine (MDMA) Intoxication in an Infant Chronically Exposed to Cocaine

Therapeutic Drug Monitoring July 22, 2005 Oscar García-algar, Nuria L Pez, M. Á. Bonet et al. 39 citations

Accidental ingestion of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) was detected in an infant admitted at the Pediatric Emergency Department by drug testing in urine. Concentrations of MDMA and its principal metabolite 4-hydroxy-3-methoxymethamphetamine (HMMA) in the infant's hydrolyzed urine were 11.7 mg/L and 34.4 mg/L, respectively. Apparent febrile convulsions and cardiovascular side...

Role of α2A‐adrenoceptors in the effects of MDMA on body temperature in the mouse

British Journal of Pharmacology July 18, 2005 Sotiria Bexis, James R. Docherty 43 citations

3,4‐Methylenedioxymetamphetamine (MDMA) produces complex effects on body temperature, including hypo‐ and hyperthermic components that vary with ambient temperature and strain of rat. We have previously reported that MDMA is an α 2 ‐adrenoceptor agonist, and α 2 ‐adrenoceptor agonists such as clonidine produce hypothermia. The purpose of this study was to investigate the effects of MDMA on core...

DOI: 10.1038/sj.bjp.0706320 (opens in new tab) MDMA Hypothermia Hyperthermia Clonidine +4

Mental disorders in current and former heavy ecstasy (MDMA) users

Addiction July 15, 2005 Rainer Thomasius, Kay Uwe Petersen, P. Zapletalova et al. 54 citations

ABSTRACT Background Ecstasy use has often been found to be associated with psychopathology, yet this research has so far been based largely on subjective symptom ratings. Aims To investigate whether ecstasy users suffered from long‐term psychopathological consequences. Measurements We compared the prevalence of Diagnostic and Statistical Manual version IV (DSM‐IV) mental disorders in 30 current...

Age-dependent (+)MDMA-mediated Neurotoxicity in Mice

Neurotoxicology July 6, 2005 María E. Reverón, Terrence J. Monks, Christine L. Duvauchelle 24 citations

In the present study the effects of a neurotoxic regimen of (+)-MDMA (20 mg/kgx4, s.c.) in 4- and 10-week-old C57Bl/6J mice during treatment and 7 days post-treatment were examined. Rectal temperatures monitored between (+)-MDMA injections (30 min post-injection/2 h intervals) revealed hyperthermic responses in both age groups, with the magnitude of the response significantly greater in older...

Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures

British Journal of Pharmacology July 4, 2005 Alfred Richard Green, Esther O’shea, Kathryn S. Saadat et al. 70 citations

3,4‐Methylenedioxymethamphetamine (MDMA, ‘ecstasy’) administration to rats produces hyperthermia if they are housed in normal or warm ambient room temperature ( T a ) conditions (20°C), but hypothermia when in cool conditions ( T a 17°C). We have now investigated some of the mechanisms involved. MDMA (5 mg kg −1 i.p.) produced a rapid decrease in rectal temperature in rats at T a 15°C. This...

Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature

Drug and Alcohol Review July 1, 2005 Joachim D. Uys, Raymond J.m. Niesink 35 citations

Epidemiological studies show that the use of club drugs is on the rise. Furthermore, the last few decades have seen a rise in patterns of polydrug use. One of the combinations frequently used is ecstasy (MDMA) with gammahydroxybutyrate (GHB). For effective prevention it is important to be aware of this phenomenon and of the pharmacology of these drugs. The effects of the combination extend to...

MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task

Journal of Psychopharmacology June 27, 2005 Franz X. Vollenweider, Matthias E. Liechti, Martin P. Paulus 24 citations

Decision-making, i.e. selecting an action from a number of alternatives when the outcome is uncertain, is a complex process that is important for everyday life. 3,4-Methylenedioxymethamphetamine (MDMA), also known as 'Ecstasy', is a widely used recreational drug that is known to increase serotonin (5-HT) and, to a lesser extent, dopamine (DA) in animals. This study examined whether MDMA alters...

Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.

Human psychopharmacology June 2005 R M Milani, A C Parrott, F Schifano et al.

Cannabis is one of the most common 'co-drugs' for ecstasy users. The aim of the present study was to explore self-reported psychobiological problems in ecstasy polydrug users in relation to their pattern of cannabis use. Two hundred and eighty ecstasy polydrug users were allocated into five cannabis groups according to the frequency of their cannabis use. The control group comprised 121...

Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*

Critical Care Medicine June 1, 2005 Jon E. Sprague, Petra Moze, David Caden et al. 75 citations

These data show that alpha1 and beta3-adrenergic receptors may contribute to the mediation of MDMA-induced hyperthermia and that drugs targeting these receptors, such as carvedilol, warrant further investigation as novel therapies for the treatment of psychostimulant-induced hyperthermia and its sequelae.

Can psychedelics have a role in psychiatry once again?

The British Journal of Psychiatry June 1, 2005 Ben Sessa 97 citations

Psychedelic or hallucinogenic drugs such as lysergic acid diethylamide (LSD), 3, 4, 5-trimethoxy-β-phenethylamine (mescaline), psilocybin, 3, 4-methylenedioxymethamph-etamine (MDMA), N, N-dimethyltrypta-mine (DMT) and their relations occur in abundance throughout the natural world, and have been used by humankind for thousands of years.

Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users.

Psychopharmacology May 2005 M Rizzo, C T J Lamers, C G Sauer et al.

Illicit drug use can increase driver crash risk due to loss of control over vehicle trajectory. This study asks, does recreational use of +/-3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) and tetrahydrocannabinol (THC; marijuana) impair cognitive processes that help direct our safe movement through the world? This study assesses the residual effects of combined MDMA/THC use, and of THC use...